Comparative Pharmacology
Head-to-head clinical analysis: POTASSIUM CHLORIDE 0 22 IN DEXTROSE 5 IN PLASTIC CONTAINER versus SODIUM PHOSPHATES.
Peer-Reviewed Evidence
Head-to-head clinical analysis: POTASSIUM CHLORIDE 0 22 IN DEXTROSE 5 IN PLASTIC CONTAINER versus SODIUM PHOSPHATES.
POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% IN PLASTIC CONTAINER vs SODIUM PHOSPHATES
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Potassium is the principal intracellular cation and is essential for maintaining cellular membrane potential, nerve impulse transmission, and muscle contraction. Dextrose provides calories and may prevent ketosis.
Sodium phosphates act as a source of phosphate and sodium ions. Phosphate is an essential component of bone mineral, cell membranes, and energy metabolism. It also acts as a buffer in acid-base balance. In the gastrointestinal tract, hyperosmotic sodium phosphate solution draws water into the lumen, inducing bowel evacuation.
Intravenous; typical adult dose is 10-20 mEq/hour, not exceeding 40 mEq/hour or 150 mEq/day, with continuous cardiac monitoring and serum potassium monitoring.
Oral: 3.75-7.5 g (15-30 mmol phosphate) 1-4 times daily. IV: 0.3-0.5 mmol/kg over 6-12 hours.
None Documented
None Documented
The elimination half-life of potassium is not applicable in the traditional sense because potassium is an endogenous ion under tight homeostatic control. After intravenous infusion of a potassium load, the plasma concentration declines with a distribution phase of about 1-2 hours, followed by a slower elimination phase reflecting cellular uptake and renal excretion, with a terminal half-life of approximately 6-8 hours in patients with normal renal function.
Not applicable; phosphate is an endogenous ion with rapid equilibration. Serum phosphate half-life is approximately 30 minutes due to renal clearance and cellular uptake.
Renal: >90% of potassium intake is excreted by the kidneys, primarily via distal tubular secretion; fecal: <10%; minor sweat losses. In this formulation (KCl 0.22% in D5W), the potassium content is 2 mEq per 100 mL (approximately 20 mEq/L).
Renal: >90% of absorbed phosphate is excreted renally, primarily as inorganic phosphate; fecal elimination accounts for <10%.
Category C
Category C
Electrolyte Supplement
Electrolyte Supplement